Li Y, Wang Y, Tang H, Luo X, et al. TACE combined with tislelizumab and lenvatinib in the treatment of intermediate-to-advanced hepatocellular carcinoma: a retrospective real-world study. BMC Cancer 2026 Mar 21. doi: 10.1186/s12885-026-15879.
PMID: 41862827